BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36376228)

  • 1. HDR brachytherapy in keratinocyte skin carcinomas - Single center experience with analysis of clinical, dosimetric, and radiobiological factors in acute skin toxicity.
    Rodríguez Villalba S; Guirado LLorente D; Sanz Cazorla A; Perez-Calatayud J; Rembielak A
    Brachytherapy; 2023; 22(1):108-119. PubMed ID: 36376228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
    Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
    Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
    Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
    Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
    Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
    Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.
    Guix B; Finestres F; Tello J; Palma C; Martinez A; Guix J; Guix R
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):95-102. PubMed ID: 10758310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate brachytherapy with surface applicator in penile cancer.
    Saldi S; Zucchetti C; Fulcheri CPL; Saccia S; Alì E; Marani S; Ingrosso G; Aristei C
    Brachytherapy; 2021; 20(4):835-841. PubMed ID: 33994341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy.
    Rodríguez S; Arenas M; Gutierrez C; Richart J; Perez-Calatayud J; Celada F; Santos M; Rovirosa A
    Clin Transl Oncol; 2018 Apr; 20(4):431-442. PubMed ID: 28808925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of volumetric modulated arc therapy (VMAT) and high-dose-rate brachytherapy (HDR-BT) for superficial skin irradiation with significant curvature in one or more planes.
    Wills RJ; Lowe G; Jones CL; Hoskin PJ
    Strahlenther Onkol; 2021 Jun; 197(6):547-554. PubMed ID: 33791816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different sizes of Valencia applicators in non-melanoma skin cancer treatment with iridium-192 high-dose-rate brachytherapy.
    Laliscia C; Coccia N; Fuentes T; Perrone F; Paiar F
    J Contemp Brachytherapy; 2021 Dec; 13(6):615-619. PubMed ID: 35079246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients.
    Ríos I; Rovirosa A; Ascaso C; Valduvieco I; Herreros A; Castilla L; Sabater S; Holub K; Pahisa J; Biete A; Arenas M
    Clin Transl Oncol; 2016 Sep; 18(9):925-30. PubMed ID: 26661111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
    Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
    Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
    Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
    Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy.
    Kellas-Ślęczka S; Białas B; Fijałkowski M; Wojcieszek P; Szlag M; Cholewka A; Wesołowski M; Ślęczka M; Krzysztofiak T; Larysz D; Kołosza Z; Trzaska K; Pruefer A
    Brachytherapy; 2019; 18(4):493-502. PubMed ID: 31101437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose rate brachytherapy in the management of anal cancer: A review.
    Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
    Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.
    Sakurai T; Takamatsu S; Shibata S; Iwata K; Taka M; Gabata T; Kumano T; Makino T; Mizokami A
    Jpn J Radiol; 2020 Dec; 38(12):1197-1208. PubMed ID: 32737768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of
    Safigholi H; Meigooni AS; Song WY
    Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
    Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
    Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDR brachytherapy for superficial non-melanoma skin cancers.
    Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.